Six-Month outcome of immunocompromised patients with severe acute respiratory distress syndrome rescued by extracorporeal membrane oxygenation. An international multicenter retrospective study
| Autor: | Matthieu Schmidt, Peter Schellongowski, Nicolò Patroniti, Fabio Silvio Taccone, Dinis Reis Miranda, Jean Reuter, Helène Prodanovic, Marc Pierrot, Amandine Dorget, Sunghoon Park, Martin Balik, Alexandre Demoule, Ilaria Alice Crippa, Alain Mercat, Philipp Wohlfarth, Romain Sonneville, Alain Combes, Lila Bouadma, Jean-Francois Timsit, Alexandre Brasseur, Olivier Lheureux, Jacques Creteur, Philippe Lemaitre, Xavier Bechtold, Gerdy Debeuckelaere, Franky Partipilo, Robert van Thiel, Corstiaan den Uil, Jan Rulisek, Petr Kopecky, Jan Kunstyr, Michela Bombino, Jonata Pizzagalli, Alessandra Ponti, Antonio Pesenti, Hyoung Soo Kim, Charles-Edouard Luyt, Nicolas Bréchot, Guillaume Hékimian, Sébastien Besset, Maxime Coutrot, Ania Nieszkowska, Simon Bourcier, Guillaume Lebreton, Pascal Leprince, Julien Mayaux, Hélène Prodanovic, Andja Bojic, Nina Buchtele, Alexander Hermann, Peter Jaksch, Oliver Robak, Wolfgang R. Sperr, Thomas Staudinger |
|---|---|
| Přispěvatelé: | International ECMO Network (ECMONet), REVA Research Network, IDEA Study Group, Schmidt, M, Schellongowski, P, Patroniti, N, Taccone, F, Reis Miranda, D, Reuter, J, Prodanovic, H, Pierrot, M, Dorget, A, Park, S, Balik, M, Demoule, A, Crippa, I, Mercat, A, Wohlfarth, P, Sonneville, R, Combes, A |
| Jazyk: | angličtina |
| Rok vydání: | 2018 |
| Předmět: |
Pulmonary and Respiratory Medicine
medicine.medical_specialty medicine.medical_treatment Acute respiratory distress Critical Care and Intensive Care Medicine 03 medical and health sciences Immunocompromised Host 0302 clinical medicine Internal medicine medicine Extracorporeal membrane oxygenation extracorporeal membrane oxygenation acute respiratory distress syndrome immunodeficiency outcome hematological malignancies Humans hematological malignancies Immunodeficiency Retrospective Studies Respiratory Distress Syndrome business.industry 030208 emergency & critical care medicine Retrospective cohort study Original Articles extracorporeal membrane oxygenation acute respiratory distress syndrome medicine.disease Respiration Artificial 3. Good health surgical procedures operative 030228 respiratory system outcome Human medicine business immunodeficiency |
| Zdroj: | Am J Respir Crit Care Med American journal of respiratory and critical care medicine |
| ISSN: | 1073-449X |
| Popis: | Rationale: Because encouraging rates for hospital and long-term survival of immunocompromised patients in ICUs have been described, these patients are more likely to receive invasive therapies, like extracorporeal membrane oxygenation (ECMO). Objectives: To report outcomes of immunocompromised patients treated with ECMO for severe acute respiratory distress syndrome (ARDS) and to identify their pre-ECMO predictors of 6-month mortality and main ECMO-related complications. Methods: Retrospective multicenter study in 10 international ICUs with high volumes of ECMO cases. Immunocompromised patients, defined as having hematological malignancies, active solid tumor, solid-organ transplant, acquired immunodeficiency syndrome, or long-term or high-dose corticosteroid or immunosuppressant use, and severe ECMO-treated ARDS, from 2008 to 2015 were included. Measurements and Main Results: We collected demographics, clinical data, ECMO-related complications, and ICU- and 6 month–outcome data for 203 patients (median Acute Physiology and Chronic Health Evaluation II score, 28 [25th–75th percentile, 20–33]; age, 51 [38–59] yr; Pa(O(2))/Fi(O(2)), 60 [50–82] mm Hg before ECMO) who fulfilled our inclusion criteria. Six-month survival was only 30%, with a respective median ECMO duration and ICU stay of 8 (5–14) and 25 (16–50) days. Patients with hematological malignancies had significantly poorer outcomes than others (log-rank P = 0.02). ECMO-related major bleeding, cannula infection, and ventilator-associated pneumonia were frequent (36%, 10%, and 50%, respectively). Multivariate analyses retained fewer than 30 days between immunodeficiency diagnosis and ECMO cannulation as being associated with lower 6-month mortality (odds ratio, 0.32 [95% confidence interval, 0.16–0.66]; P = 0.002), and lower platelet count, higher Pco(2), age, and driving pressure as independent pre-ECMO predictors of 6-month mortality. Conclusions: Recently diagnosed immunodeficiency is associated with a much better prognosis in ECMO-treated severe ARDS. However, low 6-month survival of our large cohort of immunocompromised patients supports restricting ECMO to patients with realistic oncological/therapeutic prognoses, acceptable functional status, and few pre-ECMO mortality-risk factors. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|